Article
Small Molecule Adjuvants Potentiate Colistin Activity and Attenuate Resistance Development in Escherichia coli by Affecting pmrAB System
1 Jul 2020
Abstract excerpt
Background: Colistin is one of the last-resort antibiotics to treat multi-drug resistant (MDR) Gram-negative bacterial infections in humans. Further, colistin has been also used to prevent and treat Enterobacteriaceae infections in food animals. However, chromosomal mutations and mobile colistin resistance ( mcr ) genes, which confer resistance to colistin, have been detected in bacterial isolates from food...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
